GleamWall
中文EN

USAQ QHSLab, Inc.

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 856984 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY13.1%
TTM net income YoY213.1%
TTM EPS YoY150.0%
Revenue 3-yr CAGR29.5%
Net income 3-yr CAGR—

Margins

Gross margin68.2%
Operating margin-2.2%
Net margin14.8%
FCF margin—
EBITDA margin0.3%

Returns

ROE97.8%
ROA25.1%
ROIC (approx.)-23.4%
Asset turnover1.70x

Leverage & solvency

Liabilities / assets14.1%
Debt / equity0.00x
Current ratio2.10x
Interest coverage-1.03x

Cash quality & payout

Operating cash flow / net income-0.54x
Accruals ratio38.7%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$2.69M$2.13M
Cost of revenue$880,892$774,036
Gross profit$1.81M$1.36M
R&D expense$484,873$294,479
SG&A expense$439,143$276,496
Operating income$131,244$205,738
Interest expense$237,413$465,055
Pretax income$457,417-$259,239
Net income$457,417-$259,239
EBITDA$221,972$352,313
EPS (basic)0.04-0.03
EPS (diluted)0.02-0.03
Weighted avg. shares (diluted)19.34M10.29M
Balance sheet
Cash & equivalents$636,157$157,168
Receivables$190,610$196,089
Inventory$35,790$41,779
Current assets$883,009$420,827
Intangibles$1.29M$1.36M
Total assets$2.17M$1.80M
Current liabilities$449,860$2.41M
Long-term debt$90,704—
Total debt$90,704—
Total liabilities$546,078$2.41M
Shareholders' equity$1.62M-$607,756
Net debt-$545,453—
Shares outstanding15.03M10.81M
Cash flow statement
Operating cash flow$178,118$142,437
Financing cash flow$300,871-$36,851
Depreciation & amortization$90,728$146,575
Stock-based compensation$0$0

Free plan shows the latest 2 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.